The new silicone adhesive solutions are two-component platinum-catalyzed silicone adhesives designed specifically for applications requiring a tough elastic bond between a variety of substrates
Elkem Introduces New Medical Grade Silicones at Medical Design & Manufacturing West 2021. (Credit: Shutterbug75 from Pixabay)
Elkem Silicones will introduce two new silicone adhesives to its lineup of medical grade Silbione® silicone solutions at the upcoming Medical Design and Manufacturing West conference in Anaheim, Calif., August 10 to 12.
These new silicone adhesive solutions, Silbione® MED ADH 4213 for less than 30 days contact with the body and Silbione® Biomedical ADH2 M213 for greater than 29 days contact with the body, are two-component platinum-catalyzed silicone adhesives designed specifically for applications requiring a tough elastic bond between a variety of substrates.
“Elkem is committed to market-driven innovation to help meet the evolving material needs of our customers and the medical market,” says Mike Goglia, market manager. “Now, with our expanded range of adhesives, we can offer our customers a broader range of silicone solutions from liquid silicone rubber and heat cured rubber for device design and manufacture, to one- and two-component silicone adhesives for assembly.”
In addition, Elkem’s Kyle Gaines, senior scientist, will present “Silicone Elastomers Dedicated to Additive Manufacturing, from Prototypes to Functional Parts,” at the 3D Printing eXperience Theater on August 10 at 10:45 a.m. Gaines will discuss how silicone elastomers can help balance the challenge of physico-chemical and mechanical properties in 3D printing soft materials.
Elkem Silbione® branded silicones are manufactured in a clean state-of-the-art site in York, S.C., which includes a certified ISO class 8 manufacturing environment and an ISO class 7 packaging environment. Silbione® materials are backed by biocompatibility material attestations and toxicological summaries. For medical applications of >29-day body contact, Elkem’s Silbione® Biomedical products are supported by Master Access Files (MAF), and where applicable Drug Master Files (DMF), filed with the U.S. Food and Drug Administration (FDA).
Source: Company Press Release